Fasken Martineau announced today that it acted as Canadian counsel to Concordia Healthcare Corp. (“Concordia”) in connection with its agreement to acquire UK-based Amdipharm Mercury Limited (“AMCo”). The deal is valued at US$3.5 billion which will be paid for by Concordia through a combination of cash and shares of Concordia, together with a performance-based earn-out payable in cash.
Fasken Martineau advised First Quantum on an underwriting agreement to sell 76,923,000 common shares of its stock to expand existing production facilities.
Fasken Martineau announced today that it has been awarded Global Mining Law Firm of the Year for 2015 by Who’s Who Legal.
An extensive empirical study of hostile bids initiated in Canada over the ten-year period ended December 31, 2014